Skip to main content
. 2021 Dec 22;29(1):56–62. doi: 10.1177/15910199211068673

Table 4.

Associations with progression.

Variable Aneurysm progression p-Value
No Yes
56 (86.2%) 9 (13.8%)
Age at time of treatment
 Years (median; IQR) 53 (42.5–64.5) 53 (44–68) 0.93
Female Gender 29 (51.8%) 3 (33.3%) 0.30
Multiple Intracranial Aneurysms 13 (23.2%) 2 (22.2%) 0.95
Family history of aneurysm* 5 (20.8%) 0 (0.0%) 0.26
Hypertension 24 (50.0%) 5 (71.4%) 0.29
Smoker § 12 (26.1%) 2 (33.3%) 0.71
CAD II 7 (16.3%) 2 (28.6%) 0.43
Hypercholesterolemia 15 (41.7%) 3 (50.0%) 0.70
Trauma 5 (12.5%) 0 (0.0%) 0.29
Diabetes mellitus II 5 (11.6%) 1 (14.3%) 0.84
Cancer #
 No 39 (75.0%) 9 (100.0%) 0.24
 Benign 2 (3.8%) 0 (0.0%)
 Malignant 11 (21.2%) 0 (0.0%)
Parent vessel location
 Vertebral 24 (42.9%) 3 (33.3%) 0.75
 Basilar 18 (32.1%) 4 (44.4%)
 PCA 11 (19.6%) 1 (11.1%)
 PICA 2 (3.6%) 1 (11.1%)
 AICA 1 (1.8%) 0 (0.0%)
Aneurysm symptomatic on presentation  14 (25.0%)  8 (88.9%) <0.01
Maximal diameter, mm  6 (IQR 5–8.5)  15 (IQR 11–23) <0.01
Length, mm  12 (IQR 8.95–15)  27 (IQR 18.9–36) <0.01
Ratio  0.57 (IQR 0.42–0.72)  0.59 (IQR 0.49–0.82) 0.45

Bold values: p-Value <0.05; n (%); p-Value: Chi2 test.

Median (IQR); p-Value: Mann-Whitney test.

*36 Missing data.

10 Missing data.

§13 Missing data.

II15 Missing data.

23 Missing data.

17 Missing data.

#4 Missing data.